Apalutamide

Basic Information

Item Value
DrugBank ID DB11901
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 47

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 prostate cancer/brain cancer susceptibility KG + DL
2 prostate leiomyoma KG + DL
3 Brenner tumor KG + DL
4 benign reproductive system neoplasm KG + DL
5 fibroma of prostate KG + DL
6 prostate phyllodes tumor KG + DL
7 benign neoplasm of prostate KG + DL
8 male reproductive organ cancer KG + DL
9 benign prostate phyllodes tumor KG + DL
10 palmoplantar keratoderma-sclerodactyly syndrome KG + DL
11 female breast carcinoma KG + DL
12 peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome KG + DL
13 renal cell carcinoma (disease) KG + DL
14 renal pelvis carcinoma KG + DL
15 CMM7 KG + DL
16 renal carcinoma KG + DL
17 unclassified renal cell carcinoma KG + DL
18 renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions KG + DL
19 renal cell carcinoma associated with neuroblastoma KG + DL
20 pediatric leptomeningeal melanoma KG + DL
21 melanoma KG + DL
22 epithelioid cell uveal melanoma KG + DL
23 nonpapillary renal cell carcinoma KG + DL
24 estrogen-receptor negative breast cancer KG + DL
25 bilateral breast carcinoma KG + DL
26 hormone-resistant breast carcinoma KG + DL
27 Ehrlich tumor carcinoma KG + DL
28 estrogen-receptor positive breast cancer KG + DL
29 vulvar melanoma (disease) KG + DL
30 endocrine-cerebro-osteodysplasia syndrome KG + DL
31 childhood kidney cell carcinoma KG + DL
32 breast carcinoma by gene expression profile KG + DL
33 angiolipoma KG + DL
34 chromophobe renal cell carcinoma KG + DL
35 familial spontaneous pneumothorax KG + DL
36 liposarcoma KG + DL
37 diaphyseal medullary stenosis-bone malignancy syndrome KG + DL
38 ovarian myxoid liposarcoma KG + DL
39 Mitchell-Riley syndrome KG + DL
40 simian immunodeficiency virus infection KG + DL
41 feline acquired immunodeficiency syndrome KG + DL
42 hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome KG + DL
43 sarcomatoid renal cell carcinoma KG + DL
44 prostate neoplasm KG + DL
45 HIV infectious disease KG + DL
46 clear cell renal carcinoma KG + DL
47 collecting duct carcinoma KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.